Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 40.2% in the afternoon session after the company announced a ...

GoodRx stock soars after announcing GLP-1 partnership with Novo Nordisk. A Bank of America analyst recommends selling GDRX ...

Interestingly, Wall Street firms largely believe the former will playout in the long run. According to The Wall Street ...

Hims & Hers Health ($HIMS) stock declined 2% on Monday after rival GoodRx Holdings ($GDRX) announced a deal with Novo Nordisk ...

Health Canada approved Ozempic for type 2 diabetes patients with chronic kidney disease after positive FLOW trial results.

GoodRx (Nasdaq: GDRX) has teamed up with Novo Nordisk (NOV: N) to make all dose levels of Ozempic (semaglutide) and Wegovy ...

Detailed price information for Goodrx Holdings Inc Cl A (GDRX-Q) from The Globe and Mail including charting and trades.

Detailed price information for Goodrx Holdings Inc Cl A (GDRX-Q) from The Globe and Mail including charting and trades.

Investing.com - 市值17.8亿美元的GoodRx Holdings Inc. (NASDAQ: GDRX )在周二美祖证券的研究报告中维持"中性"评级和5.00美元的目标价。该股近期表现强劲，过去一周上涨超过46%。根据 InvestingPro 分析，该公司的整体财务健康状况被评为"优秀"。

Japanese company Softbank Group (9984.T) announced on Tuesday that it had signed an agreement with Intel to buy $2bn of its ...

After shares of Novo Nordisk (NVO) fell throughout the last year, the more recent drop may be its last. The company, along with its rival Eli Lilly (LLY), will offer its obesity drug for $499 per ...

美东时间8月19日，美股三大指数在震荡中收窄日内波动，道指微跌0.08%，标普500指数近乎持平，纳指小幅收涨0.03%。市场情绪在零售财报季前趋于谨慎，投资者目光转向即将召开的杰克逊霍尔全球央行年会以及美国大选前的地缘政治动态。科技股分化，中概股集 ...